National Public TechBio Enterprise: SEO, PPC Case Study

See how a combined SEO and targeted PPC strategy drove a 76% surge in organic search clicks and cut clinical trial acquisition costs by 42% for a public TechBio enterprise. The work also captured the #1 organic ranking for the category terms that define their market.

Services Used:
PPC, SEO

Project Overview

As a clinical-stage TechBio pioneer listed on the NASDAQ, this enterprise leverages a proprietary operating system paired with one of the world's largest biological and chemical datasets to accelerate medicine discovery across oncology, rare diseases, neuroscience, and immunology. Operating out of primary hubs in North America and Europe, the organization handles every stage of machine-learning-driven target discovery while simultaneously conducting global clinical trials for rare and complex diseases. They partnered with our agency to bridge the gap between their industry-leading science and their digital discovery footprint, focusing on capturing high-intent B2B partnerships and accelerating patient recruitment for specialized clinical trials.

The Challenge

Despite standing at the absolute forefront of artificial intelligence and life science technology, the client's online footprint was not reflecting their market position or driving measurable commercial interest.

Prior to our onboarding, their growth engine faced two critical roadblocks:

  • Unclaimed High-Intent Category Search Visibility: The client was losing search visibility on critical non-branded phrases such as "AI drug discovery companies." Competitors who aggressively targeted commercial search terms were ranking above them, effectively hiding the client from potential pharma partners actively searching for technological collaborators.
  • Clinical Trial Recruitment Blindspots: While managing microsites to recruit patients for rare disease programs (including FAP, desmoid tumors, solid tumors, lymphoma, and endometrial and ovarian cancers), the client lacked proper conversion tracking infrastructure. Paid media budgets lacked safeguards against invalid clicks, making it impossible to calculate true cost-per-acquisition or evaluate trial campaign efficiency.
Lone researcher standing in a dim laboratory corridor lit by monitor glow
Scientists and marketing strategists collaborating around a conference table with laptops and charts

Our Approach

We engineered a two-pronged growth architecture designed to achieve category dominance on organic search while building an agile, highly tracked patient recruitment engine for clinical trials.

  • Technical Health Overhaul & Intent Mapping: We resolved core technical site issues and focused our SEO strategy on broad non-branded terminology that captures active prospective partners. We established multi-region visibility tracking across the US, UK, and Canada, separating natural algorithmic volatility from true rank performance to steer content and PR distribution strategically.
  • Condition-Specific PPC Campaign Architecture: To recruit qualified trial participants without ad spend waste, we built hyper-targeted Google Search campaigns segmented by individual medical condition. Each campaign used tightly constrained, high-relevance keyword lists matched directly to patient search intent.
  • Fraud Mitigation & Bid Governance: To protect the media budget, we integrated click fraud detection software to block bot traffic and implemented strict manual bid ceilings, ensuring ad dollars were spent strictly on high-value human queries.
  • End-to-End Analytics & Submission Tracking: We deployed full-funnel conversion tracking across all trial landing pages. To overcome standard browser analytics tracking limitations, we reconciled digital analytics directly against internal patient form submissions, using weekly syncs to keep performance data fully transparent.

Results

Our combined organic and paid frameworks produced immediate market dominance while creating an efficient, repeatable model for ongoing patient trial recruitment.

Performance Metric Result Growth Impact
Organic Search Clicks +76% Month-over-month growth within a single performance window
Total Search Impressions +167% Category visibility expanded across US, UK, and Canada
Average Cost Per Click -42% (to ~$14) Achieved through bid ceilings and click fraud filtering
Paid Clicks / Impressions +55% / +42% On a modest media spend of roughly $4,900
Category Keyword Rankings #1 Position Top spot for “ai drug discovery companies” and “drug development platform”
  • Explosive Organic Search Growth: Within a single one-month performance window, organic search clicks increased by 76% month-over-month, while total search impressions expanded by 167%.
  • Primary Category Dominance: The client captured the #1 organic ranking on Google for foundational industry keywords like “ai drug discovery companies” and “drug development platform,” alongside the #2 position for “ai drug companies.”
  • 42% Reduction in Cost-Per-Click (CPC): Through bid controls and fraud filtering, average CPC dropped by 42% to roughly $14 per click on a modest $4,900 media spend.
  • Elevated Campaign Engagement: Paid ad clicks rose by 55%, total campaign impressions grew by 42%, and the overall click-through rate (CTR) improved by roughly 15%.
  • Direct Patient Inquiries Captured: The paid search engine generated direct, qualified patient inquiries for complex, low-search-volume rare diseases, providing verified conversion visibility for every ad dollar spent.

76% Growth in Organic Clicks

Organic search clicks rose 76% month over month while total search impressions expanded by 167%.

#1 Category Rankings

Captured the top organic position for foundational terms including "ai drug discovery companies" and "drug development platform."

42% Lower Cost Per Click

Bid ceilings and click fraud filtering cut average CPC by 42% to roughly $14 on a modest $4,900 media budget.

55% More Paid Clicks

Condition-specific campaign architecture lifted paid clicks 55% and improved click-through rate by roughly 15%.

Takeaway

Leading-edge scientific capabilities require equal precision in digital execution. By decoupling non-branded search engine optimization from generic brand awareness and deploying condition-specific paid search architectures with robust tracking safeguards, enterprise biotech firms can capture elite market positioning while efficiently enrolling patients in rare disease clinical trials.

What’s Next?

Building on this momentum, we are expanding the top-performing clinical trial campaigns with newly validated keyword lists and prepping video ad funnels across social networks pending Institutional Review Board (IRB) approval. On the organic side, we are executing a content and PR push to amplify their proprietary research stories, elevating international search footprints across global markets, and laying the strategic groundwork for a comprehensive website refresh.